Pharmaceutical

Syngene International announces winners of its annual s...

Syngene International, an integrated research, development and manufacturing se...

Santhera grants Agamree rights to Nxera for DMD

Agamree is a new drug that operates by attaching to the same receptor as glucoco...

Takeda and Halozyme sign global agreement for Enhanze t...

Through this partnership, Takeda aims to enhance patient care while exploring ne...

Ahead of union budget, pharma industry seeks R&D boost,...

Anil Matai, Director General, OPPI: “As India approaches the upcoming Union Bud...

Quality Trailblazer emphasises that leadership commitme...

What motivated you to write Quality Trailblazer, and how does it address the mo...

Odisha’s pharma pitch

The recently held Odisha Pharma Summit 2025, the state’s first dedicated summit...

Nimesulide and patient safety: Lessons from global drug...

Recently, the Indian Ministry of Health and Family Welfare issued a government ...

Granules Pharmaceuticals receives FDA tentative approva...

Granules Pharmaceuticals, a wholly owned subsidiary of Granules India, has rece...

Octapharma receives FDA approval for new Fibryga formul...

The approval offers healthcare providers with an additional option alongside the...

Day One concludes Mersana Therapeutics acquisition

The tender offer expired on 5 January 2026. The transaction involved purchasing ...

Sharp Sterile Manufacturing increases capacity with $28...

Sharp Sterile Manufacturing has announced a $28 million expansion of its site i...

Supriya Lifescience ramps up capacity and global readin...

Supriya Lifescience has built a strong global presence in Active Pharmaceutical...

We are cost-competitive and aligned with global ESG fra...

The biologics sector is very dependent on single-use products and containment s...

Cellenkos gains FDA orphan drug status for CK0804 to tr...

The condition has an estimated prevalence of 25,000 patients in the US and an an...

Zai Lab’s Augtyro receives NMPA approval for solid tumo...

The approval applies to patients whose disease is metastatic or locally advanced...

Sigachi Industries appoints Atul Dhavle as Chief People...

Sigachi Industries, a leading global manufacturer of pharmaceutical excipients ...